Drug-induced heart failure

J Feenstra, DE Grobbee, WJ Remme… - Journal of the American …, 1999 - jacc.org
Heart failure is a clinical syndrome that is predominantly caused by cardiovascular disorders
such as coronary heart disease and hypertension. However, several classes of drugs may …

The mystery of bradyasystole during cardiac arrest

JP Ornato, MA Peberdy - Annals of emergency medicine, 1996 - Elsevier
The Mystery of Bradyasystole During Cardiac Arrest - ScienceDirect Skip to main contentSkip to
article Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue …

Systemic adverse effects of topical ophthalmic agents: implications for older patients

JP Diamond - Drugs & aging, 1997 - Springer
Topical ophthalmic medications are widely prescribed by growing numbers of eye-care
professionals. Increasingly, these agents are being prescribed by optometrists and …

Topical Ophthalmic β‐Adrenergic Blockade for the Treatment of Glaucoma and Ocular Hypertension

WH Frishman, MS Fuksbrumer… - The Journal of Clinical …, 1994 - Wiley Online Library
Since the late 1970s, topical β‐adrenergic blockers have been the drugs of choice in
treating ocular hypertension and associated glaucoma. The currently available drugs are …

Side effects of timolol

TJ Zimmerman, JD Baumann, J Hetherington Jr - Survey of ophthalmology, 1983 - Elsevier
Timolol maleate, a nonselective beta blocker, has been associated with adverse reactions
when administered topically or systemically. The current literature pertaining to timolol …

Systemic side effects associated with the ophthalmic administration of timolol

WP Munroe, JP Rindone… - Drug intelligence & …, 1985 - journals.sagepub.com
Since the introduction of ophthalmic timolol solution in 1978 there have been numerous
reports of systemic toxicity associated with its use. The majority of the systemic side effects …

Systemic adverse effects of ophthalmic β-blockers

JAV Zanden, RJ Valuck, CL Bunch… - Annals of …, 2001 - journals.sagepub.com
OBJECTIVE: To review published clinical information on the systemic adverse effects of
ophthalmic β-blockers for the purpose of developing a pilot contraindication/warning system …

Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension

JA Han, WH Frishman, SW Sun, PM Palmiero… - Cardiology in …, 2008 - journals.lww.com
Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

Third degree AV block due to ophthalmic timolol solution

M Sharifi, JM Koch, RJ Steele, D Adler… - International journal of …, 2001 - Elsevier
3. Discussion Ophthalmic timolol maleate is a nonselective topical beta-adrenergic receptor
blocking agent without significant sympathomimetic, direct myocardial depressant and …

Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for. beta.-adrenergic …

N Bodor, A ElKoussi, M Kano… - Journal of medicinal …, 1988 - ACS Publications
Novel ketoxime analogues of known/3-blockers (propranolol, timolol, carteolol) were
synthesized and tested as potential site-specific chemical delivery systems. It was assumed …